You may recall seeing Dr. Robert Jarvik‘s pleasant face on your TV screen a few years ago flogging Lipitor, the biggest-selling drug on the planet at that time, earning well over $12 billion a year for Pfizer – the biggest drug company on the planet.
This partnership emerged just as the company was seeking to protect Lipitor from emerging competition by cheaper generics, and just before a U.S. Congressional investigation started looking into Jarvik’s credentials and his controversial role as paid pitchman for the cholesterol-lowering statin drug. Continue reading →
Is it just me, or does this Italian cholesterol drug ad for the Novartis statin called Lescol (fluvastatina in Italian) look like it’s telling cute fat Italians that they can eat, drink, and be merry as long as they pop this statin drug every day?
And it’s about time. The Food & Drug Administration in the U.S. is looking for tattle-tales who are fed up with aggressive prescription drug advertising and promotion practices that skate around the truth. For the sake of clarity, let’s call this “lying”. The FDA’s new and long overdue‘Bad Ad Program’ is asking health care professionals to recognize and report sleazy tactics in:
Big Pharma TV, radio and print advertising
all presentations by pharmaceutical sales reps
all presentations by physicians who are being paid by Big Pharma
all written or printed prescription drug promotional materials
Here are three examples of the ‘bad ads’ that concerned health care professionals are now being asked to look out for: Continue reading →
Bayer’s recent ad claims have become a real headache for the German drug company. The Center for Science in the Public Interest filed a lawsuit on September 30 against Bayer over ad claims for its One A Day Men’s Health Formula multi-vitamins. Bayer says that because its product contains selenium, it may reduce the risk of prostate cancer, which CSPI said has been proven false.
The nonprofit health advocacy group said it reached out to Bayer in June 2009, asking it to alter its marketing materials following the results of an eight-month clinical trial that showed that selenium does not prevent prostate cancer. It also showed selenium may actually have harmful affects such as an increased risk of diabetes. CSPI reported that Bayer threatened to sue for libel after the group spotlighted the alleged flaws in Bayer’s claims. And no wonder – Bayer pocketed almost $24 million in sales on this product during the past year.
Bayer might want to visit the Mayo Clinic website before it launches that libel suit. Mayo Clinic doctors apparently agree with CSPI:
“Some companies have suggested that daily doses of the mineral selenium, vitamin E or both may have helped to prevent prostate cancer. But further study has shown these supplements have no effect on prostate cancer. In some cases, these supplements may cause side effects or lead to other health conditions.”